fda update on tirzepatide BREAKING NEWS!!! A weight loss drug more effective than Semaglutide has been approved by the today. (Zepbound for weight loss and Mounjaro for diabetes) showed a 15-20.9% weight change in Prescriber Insights: Navigating FDA Updates

Those indications are exclusions, and they would go through our normal Medicare Part D coverage, even if your insurance does not give coverage for those things or even if your insurance makes it cost more than this program, which is a $50 per month payment

In this regard, semaglutide is becoming increasingly important, as demonstrated in Table 3, which summarizes the previous results of phase 3 clinical trials

These factors are built into the pricing to ensure both efficiency and effectiveness in achieving your health goals

Contact your prescribing clinician, dispensing pharmacist, or clinical trial coordinator for advice before proceeding